Previous close | 50.58 |
Open | 50.57 |
Bid | 49.88 x 0 |
Ask | 49.99 x 0 |
Day's range | 49.82 - 50.57 |
52-week range | 47.60 - 58.25 |
Volume | |
Avg. volume | 15,684 |
Market cap | 1.805T |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 19.58 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.74 (3.44%) |
Ex-dividend date | 20 May 2024 |
1y target est | N/A |
AbbVie's (ABBV) first-quarter earnings and sales beat estimates. Management hikes the EPS guidance on the back of encouraging Skyrizi product sales.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Five stocks to focus with recent dividend hike are: JNJ, TRV, SON, KBH, SPFI.